Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nathan Luebbering is active.

Publication


Featured researches published by Nathan Luebbering.


Science Signaling | 2010

Characterization of a Domain That Transiently Converts Class 2 DYRKs into Intramolecular Tyrosine Kinases

Ross Kinstrie; Nathan Luebbering; Diego Miranda-Saavedra; Gary Sibbet; Jingfen Han; Pamela A. Lochhead; Vaughn Cleghon

An N-terminal region of a dual-specificity kinase temporarily enables it to phosphorylate a tyrosine rather than a serine or a threonine residue. Temporary Specificity Many protein kinases must undergo phosphorylation of particular amino acid residues in their activation loops to become activated. Such reactions can occur in an intermolecular manner, either by another kinase or by another molecule of the same kinase, or through an intramolecular mechanism. The dual-specificity tyrosine phosphorylation–regulated kinases (DYRKs) represent one of two families of kinases whose activation loop tyrosine residue is phosphorylated intramolecularly. However, DYRKs phosphorylate their substrates on serine or threonine residues, so it is unclear how a single kinase domain can have both activities. Kinstrie et al. characterized deletion mutants of the Drosophila class II DYRK, dDYRK2, and demonstrated that a noncatalytic, N-terminal region of the protein was required for autophosphorylation of the activation loop tyrosine, but not for the serine-threonine phosphorylation of substrates. The authors propose that this region, which they term the NAPA domain, acts as a chaperone, analogous to the function of heat shock protein 90 in mediating the autophosphorylation of activation loop tyrosines by the GSK-3 family of kinases, the other family to undergo intramolecular phosphorylation. Dual-specificity tyrosine phosphorylation–regulated kinases (DYRKs) autophosphorylate an essential tyrosine residue in their activation loop and phosphorylate their substrates on serine and threonine residues. Phosphorylation of the activation loop tyrosine occurs intramolecularly, is mediated by a short-lived transitional intermediate during protein maturation, and is required for functional serine-threonine kinase activity of DYRKs. The DYRK family is separated into two subclasses. Through bioinformatics and mutational analyses, we identified a conserved domain in the noncatalytic N terminus of a class 2 DYRK that was required for autophosphorylation of the activation loop tyrosine but not for the phosphorylation of serine or threonine residues in substrates. We propose that this domain, which we term the NAPA domain, provides a chaperone-like function that transiently converts class 2 DYRKs into intramolecular kinases capable of autophosphorylating the activation loop tyrosine. The conservation of the NAPA domain from trypanosomes to humans indicates that this form of intramolecular phosphorylation of the activation loop is ancient and may represent a primordial mechanism for the activation of protein kinases.


PLOS ONE | 2012

Deep evolutionary conservation of an intramolecular protein kinase activation mechanism.

Jingfen Han; Diego Miranda-Saavedra; Nathan Luebbering; Aman P. Singh; Gary Sibbet; Michael A. J. Ferguson; Vaughn Cleghon

DYRK-family kinases employ an intramolecular mechanism to autophosphorylate a critical tyrosine residue in the activation loop. Once phosphorylated, DYRKs lose tyrosine kinase activity and function as serine/threonine kinases. DYRKs have been characterized in organisms from yeast to human; however, all entities belong to the Unikont supergroup, only one of five eukaryotic supergroups. To assess the evolutionary age and conservation of the DYRK intramolecular kinase-activation mechanism, we surveyed 21 genomes representing four of the five eukaryotic supergroups for the presence of DYRKs. We also analyzed the activation mechanism of the sole DYRK (class 2 DYRK) present in Trypanosoma brucei (TbDYRK2), a member of the excavate supergroup and separated from Drosophila by ∼850 million years. Bioinformatics showed the DYRKs clustering into five known subfamilies, class 1, class 2, Yaks, HIPKs and Prp4s. Only class 2 DYRKs were present in all four supergroups. These diverse class 2 DYRKs also exhibited conservation of N-terminal NAPA regions located outside of the kinase domain, and were shown to have an essential role in activation loop autophosphorylation of Drosophila DmDYRK2. Class 2 TbDYRK2 required the activation loop tyrosine conserved in other DYRKs, the NAPA regions were critical for this autophosphorylation event, and the NAPA-regions of Trypanosoma and human DYRK2 complemented autophosphorylation by the kinase domain of DmDYRK2 in trans. Finally, sequential deletion analysis was used to further define the minimal region required for trans-complementation. Our analysis provides strong evidence that class 2 DYRKs were present in the primordial or root eukaryote, and suggest this subgroup may be the oldest, founding member of the DYRK family. The conservation of activation loop autophosphorylation demonstrates that kinase self-activation mechanisms are also primitive.


Blood | 2017

Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD

Nicholas J. Gloude; Pooja Khandelwal; Nathan Luebbering; Dana T. Lounder; Sonata Jodele; Matthew N. Alder; Adam Lane; Alyss Wilkey; Kelly E. Lake; Bridget Litts; Stella M. Davies

Transplant-associated thrombotic microangiopathy (TA-TMA) is a common and poorly recognized complication of hematopoietic stem cell transplantation (HSCT) associated with excessive complement activation, likely triggered by endothelial injury. An important missing piece is the link between endothelial injury and complement activation. We hypothesized that neutrophil extracellular traps (NETs) mechanistically link endothelial damage with complement activation and subsequent TA-TMA. Neutrophil activation releases granule proteins together with double-stranded DNA (dsDNA) to form extracellular fibers known as NETs. NETs have been shown to activate complement and can be assessed in humans by quantification of dsDNA in serum. We measured levels of dsDNA, as a surrogate for NETs in 103 consecutive pediatric allogeneic transplant recipients at day 0, +14, +30, +60, and +100. A spike in dsDNA production around day +14 during engraftment was associated with subsequent TA-TMA development. Peak dsDNA production around day +14 was associated with interleukin-8-driven neutrophil recovery. Increased dsDNA levels at days +30, +60, and +100 were also associated with increased mortality and gastrointestinal graft-versus-host disease (GVHD). NETs may serve as a mechanistic link between endothelial injury and complement activation. NET formation may be one mechanism contributing to the clinical overlap between GVHD and TA-TMA.


PLOS ONE | 2013

Drosophila Dyrk2 plays a role in the development of the visual system.

Nathan Luebbering; Mark Charlton-Perkins; Justin P. Kumar; Stephanie M. Rollmann; Tiffany Cook; Vaughn Cleghon

The DYRKs (dual-specificity tyrosine phosphorylation-regulated kinases) are a conserved family of protein kinases that are associated with a number of neurological disorders, but whose biological targets are poorly understood. Drosophila encodes three Dyrks: minibrain/Dyrk1A, DmDyrk2, and DmDyrk3. Here we describe the creation and characterization of a DmDyrk2 null allele, DmDyrk21w17. We provide evidence that the smell impaired allele smi35A1, is likely to encode DmDyrk2. We also demonstrate that DmDyrk2 is expressed late in the developing third antennal segment, an anatomical structure associated with smell. In addition, we find that DmDyrk2 is expressed in the morphogenetic furrow of the developing eye, that loss of DmDyrk2 in the eye produced a subtle but measurable defect, and that ectopic DmDyrk2 expression in the eye produced a strong rough eye phenotype characterized by increased secondary, tertiary and bristle interommatidial cells. This phenotype was dependent on DmDyrk2 kinase activity and was only manifest when expressed in post-mitotic non-neuronal progenitors. Together, these data indicate that DmDyrk2 is expressed in developing sensory systems, that it is required for the development of the visual system, and that the eye is a good model to identify DmDyrk2 targets.


Blood Advances | 2017

In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy

Seth Joshua Rotz; Nathan Luebbering; Bradley P. Dixon; Eleni Gavriilaki; Robert A. Brodsky; Christopher E. Dandoy; Sonata Jodele; Stella M. Davies

Transplantation-associated thrombotic microangiopathy is associated with complement activation in vitro.This data further supports the use of eculizumab for the treatment of patients with TA-TMA.


Biology of Blood and Marrow Transplantation | 2017

In Vitro Evidence of Complement Activation in Transplant Associated-Thrombotic Microangiopathy

Seth Joshua Rotz; Nathan Luebbering; Bradley P. Dixon; Christopher E. Dandoy; Eleni Gavriilaki; Sonata Jodele; Stella M. Davies


Biology of Blood and Marrow Transplantation | 2018

Antibiotic Exposure and Reduced Short Chain Fatty Acid Production after Hematopoietic Stem Cell Transplant

Lindsey E. Romick-Rosendale; David Haslam; Adam Lane; Lee A. Denson; Kelly E. Lake; Alyss Wilkey; Miki Watanabe; Stuart B. Bauer; Bridget Litts; Nathan Luebbering; Christopher E. Dandoy; Stella M. Davies


Biology of Blood and Marrow Transplantation | 2018

Functional Studies of Elevated Vitamin D Binding Protein after Stem Cell Transplant

Nathan Luebbering; Dana T. Lounder; Stella M. Davies


Biology of Blood and Marrow Transplantation | 2018

Short Chain Fatty Acids are Reduced after Hematopoietic Stem Cell Transplant in Humans and are Associated with Modifications of the Gut Microbiome

Lindsey E. Romick-Rosendale; David Haslam; Adam Lane; Kelly E. Lake; Miki Watanabe; Stuart B. Bauer; Bridget Litts; Nathan Luebbering; Christopher E. Dandoy; Stella M. Davies


Biology of Blood and Marrow Transplantation | 2018

Complement and Interferon Pathway Activation Triggers Thrombotic Microangiopathy after Stem Cell Transplantation

Sonata Jodele; Nathan Luebbering; Mario Medvedovic; Jenny Chen; Stella M. Davies

Collaboration


Dive into the Nathan Luebbering's collaboration.

Top Co-Authors

Avatar

Stella M. Davies

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Adam Lane

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Sonata Jodele

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kelly E. Lake

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Christopher E. Dandoy

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Bridget Litts

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dana T. Lounder

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

David Haslam

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Lindsey E. Romick-Rosendale

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar

Nicholas J. Gloude

Cincinnati Children's Hospital Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge